Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Overexpression of an activated REL mutant enhances the transformed state of the human B-lymphoma BJAB cell line and alters its gene expression profile.

Chin M, Herscovitch M, Zhang N, Waxman DJ, Gilmore TD.

Oncogene. 2009 May 21;28(20):2100-11. doi: 10.1038/onc.2009.74.

2.

NF-kappaB down-regulates expression of the B-lymphoma marker CD10 through a miR-155/PU.1 pathway.

Thompson RC, Herscovitch M, Zhao I, Ford TJ, Gilmore TD.

J Biol Chem. 2011 Jan 21;286(3):1675-82. doi: 10.1074/jbc.M110.177063.

3.

Mutation of an IKK phosphorylation site within the transactivation domain of REL in two patients with B-cell lymphoma enhances REL's in vitro transforming activity.

Starczynowski DT, Trautmann H, Pott C, Harder L, Arnold N, Africa JA, Leeman JR, Siebert R, Gilmore TD.

Oncogene. 2007 Apr 26;26(19):2685-94.

PMID:
17072339
4.
5.

Methods for assessing the in vitro transforming activity of NF-κB transcription factor c-Rel and related proteins.

Gilmore TD, Gélinas C.

Methods Mol Biol. 2015;1280:427-46. doi: 10.1007/978-1-4939-2422-6_26.

PMID:
25736765
6.

NFkappaB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes.

Feuerhake F, Kutok JL, Monti S, Chen W, LaCasce AS, Cattoretti G, Kurtin P, Pinkus GS, de Leval L, Harris NL, Savage KJ, Neuberg D, Habermann TM, Dalla-Favera R, Golub TR, Aster JC, Shipp MA.

Blood. 2005 Aug 15;106(4):1392-9.

7.

BAFF-R promotes cell proliferation and survival through interaction with IKKbeta and NF-kappaB/c-Rel in the nucleus of normal and neoplastic B-lymphoid cells.

Fu L, Lin-Lee YC, Pham LV, Tamayo AT, Yoshimura LC, Ford RJ.

Blood. 2009 May 7;113(19):4627-36. doi: 10.1182/blood-2008-10-183467.

8.

The IKK2/NF-{kappa}B pathway suppresses MYC-induced lymphomagenesis.

Klapproth K, Sander S, Marinkovic D, Baumann B, Wirth T.

Blood. 2009 Sep 17;114(12):2448-58. doi: 10.1182/blood-2008-09-181008.

9.

Inhibition of Oncogenic Transcription Factor REL by the Natural Product Derivative Calafianin Monomer 101 Induces Proliferation Arrest and Apoptosis in Human B-Lymphoma Cell Lines.

Yeo AT, Chennamadhavuni S, Whitty A, Porco JA Jr, Gilmore TD.

Molecules. 2015 Apr 23;20(5):7474-94. doi: 10.3390/molecules20057474.

10.

Regulation of the IL-21 gene by the NF-κB transcription factor c-Rel.

Chen G, Hardy K, Bunting K, Daley S, Ma L, Shannon MF.

J Immunol. 2010 Aug 15;185(4):2350-9. doi: 10.4049/jimmunol.1000317.

11.

Genome-wide analysis of gene expression in T cells to identify targets of the NF-kappa B transcription factor c-Rel.

Bunting K, Rao S, Hardy K, Woltring D, Denyer GS, Wang J, Gerondakis S, Shannon MF.

J Immunol. 2007 Jun 1;178(11):7097-109.

12.
13.

BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms.

Parekh S, Polo JM, Shaknovich R, Juszczynski P, Lev P, Ranuncolo SM, Yin Y, Klein U, Cattoretti G, Dalla Favera R, Shipp MA, Melnick A.

Blood. 2007 Sep 15;110(6):2067-74.

14.

Mouse mammary tumor virus c-rel transgenic mice develop mammary tumors.

Romieu-Mourez R, Kim DW, Shin SM, Demicco EG, Landesman-Bollag E, Seldin DC, Cardiff RD, Sonenshein GE.

Mol Cell Biol. 2003 Aug;23(16):5738-54.

15.

Malignant transformation of primary chicken spleen cells by human transcription factor c-Rel.

Gilmore TD, Cormier C, Jean-Jacques J, Gapuzan ME.

Oncogene. 2001 Oct 25;20(48):7098-103.

16.

Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphoma.

Li L, Xu-Monette ZY, Ok CY, Tzankov A, Manyam GC, Sun R, Visco C, Zhang M, Montes-Moreno S, Dybkaer K, Chiu A, Orazi A, Zu Y, Bhagat G, Richards KL, Hsi ED, Choi WW, van Krieken JH, Huh J, Ponzoni M, Ferreri AJ, Møller MB, Wang J, Parsons BM, Winter JN, Piris MA, Pham LV, Medeiros LJ, Young KH.

Oncotarget. 2015 Sep 15;6(27):23157-80.

17.

Inhibitor of kappa B epsilon (IκBε) is a non-redundant regulator of c-Rel-dependent gene expression in murine T and B cells.

Clark JM, Aleksiyadis K, Martin A, McNamee K, Tharmalingam T, Williams RO, Mémet S, Cope AP.

PLoS One. 2011;6(9):e24504. doi: 10.1371/journal.pone.0024504.

18.

Lack of IKBA coding region mutations in primary mediastinal large B-cell lymphoma and the host response subtype of diffuse large B-cell lymphoma.

Takahashi H, Feuerhake F, Monti S, Kutok JL, Aster JC, Shipp MA.

Blood. 2006 Jan 15;107(2):844-5. No abstract available.

19.

Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively.

Tracey L, Pérez-Rosado A, Artiga MJ, Camacho FI, Rodríguez A, Martínez N, Ruiz-Ballesteros E, Mollejo M, Martinez B, Cuadros M, Garcia JF, Lawler M, Piris MA.

J Pathol. 2005 Jun;206(2):123-34.

PMID:
15880597
20.

Activation of the transcriptional function of the NF-κB protein c-Rel by O-GlcNAc glycosylation.

Ramakrishnan P, Clark PM, Mason DE, Peters EC, Hsieh-Wilson LC, Baltimore D.

Sci Signal. 2013 Aug 27;6(290):ra75. doi: 10.1126/scisignal.2004097. Erratum in: Sci Signal. 2014 Apr 29;7(323):er3.

Supplemental Content

Support Center